“Major step”, “first great success”, the “tremendous joy” of Amoéba after a first support in Europe for the use of its natural pesticide


Amoéba announced with “great joylate afternoon yesterday on Twitter, that the Austrian authority in charge of the request for evaluation of the ‘biocontrol’ substance recommends its approval for use in plant protection in Europe. » The producer of biological biocides, which gained up to nearly 45% this morning on the stock market, enough to allow its action to resume the threshold of 1 euro abandoned in January, says a little more in a press release. Lyon cleantech indicates “that the AGES (Agentur für Gesundheit und Ernährungssicherheit), the competent authority of the reporting Member State […] concludes that the active substance is likely to meet the approval criteria. The Austrian authority thus confirms the effectiveness of [Lysat de Willaertia magna C2c Maky »] and its absence of harmful effects on human health and the environment. »

On the basis of this conclusion, Austria recommends to the other Member States of the European Union and to the European Food Safety Agency (EFSA) the approval and its inclusion in the list of approved plant protection active substances.

Amoéba discovered that the amoeba “Willaertia magna C2c Maky”, developed since 2010, had strong fungicidal properties. These microorganisms are able to eliminate the bacterial risk in plants, but also in water and human wounds.

-90% since IPO

“Austria’s recommendation for approval is a major step for Amoéba, leading to the future marketing of our biocontrol products”, welcomes the regulatory director, Jean-Baptiste Eberst. And the CEO, Fabrice Plasson, to add: “Austria’s favorable decision for the use of the active substance in biocontrol application is synonymous with a first major success for Amoéba. This positive conclusion opens the way to great opportunities and strongly encourages us to explore the full potential of this substance in different fields of application. »

Last summer, at the end of a second campaign of field trials, conducted in France, Italy and Germany, Amoéba had confirmed the potential of its biofungicide on cereals. The company’s biofungicides are certainly less effective than chemical products but, with a success rate of around 50%, they are more effective than other natural products.

Amoéba was floated on the stock exchange in July 2015 at a price of 8.3 euros. Since then, its shares (which traded at a daily high of 1.9 euros) have seen their value fall by 90%. At a historic low, in November 2019, they had even fallen below 40 cents. In 2018, the European Biocidal Products Committee issued a negative opinion on the approval of “Willaertia magna C2c Maky” for the cooling tower market, where legionella strains proliferate in particular.




Source link -91